Purpose. Spondylodiscitis as a rare disease has increased in recent years; there are only a few recommendations regarding the diagnostics and treatment. The objective of this retrospective study was to characterise these patients and identify factors for a favourable healing process -with an emphasis on antibiotic therapy.
INTRODUCTION
Spondylodiscitis (infection of the intervertebral disc and adjacent vertebral bodies), with approximately 2-6 cases per 100 000 inhabitants [1] [2] [3] , was a rare infectious disease, primarily of advanced age. However, in recent years, an increase in the overall incidence has been observed, probably as a result of a population that is becoming older, an increase in invasive procedures and immunosuppressive therapies, and improved diagnostic options [3, 4] .
As part of antimicrobial stewardship programs, these patients are increasingly being seen as 'problem patients', who require long-term interdisciplinary treatment planning. However, thus far, there are few guidelines for the diagnostics and treatment for bacterial spondylodiscitis: French guidelines were published in 2007 [5] and American guidelines in 2015 [6] .
The objective of this study was to describe patients with spondylodiscitis statistically (age, gender, medical history; internal medicine/neurological status; radiological, laboratory chemistry, and microbiological findings; possible focus of the infection) and to investigate which of these factors or which of the conducted treatment regimen had a favourable effect on the clinical course. The emphasis here was on antibiotic therapy (antibiotic selection, administration route, treatment duration) in order to develop recommendations for optimal antibiotic therapy for spondylodiscitis.
METHODS
In this retrospective noninterventional study, data were collected from all adult patients treated for bacterial spondylodiscitis from January 2012 to December 2013 at the HELIOS Clinics of Schwerin, a tertiary care hospital in Germany. There was a positive ethics committee vote from the Ethics Committee at the Faculty of Medicine of the University of Rostock (A 2016-0097).
For this purpose the (electronic/paper) patient files of all patients discharged with the diagnosis 'spondylodiscitis/ infection of intervertebral disc' (M46. -according to the ICD-10-code) and 'spondylitis of different causes' including tuberculosis and brucellosis (M49. -according to the ICD-10-code) -additionally of all patients who underwent CTguided punctures because of discitis or abscesses -were reviewed.
(1) The radiological findings were retrospectively verified by a neuroradiologist (MRI performed as 'gold standard'*; CT in case of a MRI-contraindication**). *MRI criteria for spondylodiscitis: [7, 8] -T2-and STIR-sequences: high signal in intervertebral space, adjacent endplates, pre-and/or paravertebral soft tissues -T1-sequence: low signal in intervertebral space, adjacent endplates -T1-sequence+Gadolinium: peripheral and/or central enhancement of intervertebral space, vertebral endplates, pre-and/or paravertebral soft tissues ** CT criteria for spondylodiscitis: -Disc space narrowing and irregularity or ill definition of the vertebral endplates -Local osteopenia, cortical bone erosion, lytic fragmentation, and bony sclerosis -Surrounding soft tissue swelling with loss of fat planes -Fluid collections in paraspinal soft tissue and epidural space -After the administration of iodinated contrast material, the abnormal disk space, vertebral marrow, or paravertebral soft tissues may enhance Clear clinical criteria for spondylodiscitis (so called 'red flags') do not exist, thus the initial suspicion of spondylodiscitis depends on the experience of the physician (mainly back pain, sometimes fever, fatigue, weight loss, neurological deficits). Therefore only patients who were treated for spondylodiscitis and who clearly met the radiological criteria for spondylodiscitis were included in the evaluation. We did not asses the severity of the spondylodiscitis because classifications are still under discussion.
The following data were collected from the patient files and documented in Microsoft Excel: medical history; internal medicine/neurological status; radiological, laboratory chemistry, and microbiological findings at admission and over time (including blood culture tests, CT-guided punctates); neurosurgical or radiological interventions; and antibiotic therapy (see below). The patients were followed up for a maximum of 48 months (mean 12 months).
The patients were retrospectively assigned to the following groups:
(1) 'Timely' clinical course: A combination of clinical, laboratory, and radiological criteria were included for the evaluation of a 'timely' clinical course: Marked pain reduction no later than 14 days after the start of antibiotic therapy (minus >/=2 points based on the visual analog scale (VAS); if applicable, additional reduction in the pain medication): yes/no C-reactive protein (CRP) 28 days after the start of treatment <28 mg l
À1
: yes/no (IDSA-guideline) [6, 9] MRI (CT/PET-CT if contraindicated) [10, 11] . 14-28 days after the start of treatment: soft tissue edema decreased (bone edema could be progressive), abscesses and contrast medium uptake decreasing: yes/no . 2-4 months after the start of treatment: vertebral body edema decreasing; intervertebral disc fusion increasing; abscesses decreasing/absorbed: yes/no . If available, repeat MRI after completion of treatment 6-10 months after the start of treatment: healing of the infection (2) 'Prolonged' clinical course (above criteria not met) (3) Recurrence of the spondylodiscitis Rehospitalisation for spondylodiscitis after completion of the antibiotic therapy (located at the initial site) (4) Death as a result of an infectious complication of the spondylodiscitis (sepsis with multiorgan dysfunction) (5) Death without a recognisable correlation with the spondylodiscitis
Antibiotic therapy
The following data were collected from the patient files:
. Medication and duration of the initial intravenous therapy in days . Medication and duration of the oral follow-up therapy in weeks . Overall treatment duration in weeks The administered antibiotics were evaluated in terms of their efficacy (bactericidal effects, bioavailability, bone penetration) and classified to the following categories: 'very effective' versus 'weakly effective/ineffective medication' (Table 2) . Patients with calculated antibiotic therapy without detection of a pathogen were excluded.
In parallel, patients were categorised in terms of an initial intravenous treatment duration of at least 14 days or an overall treatment duration of at least 6 or 12 weeks.
Statistics
Because of relatively small numbers of patients, the groups with a 'prolonged' clinical course, recurrence, and infectionrelated death were summarised as 'unfavourable' and were compared with patients with a 'timely,' i.e. 'favourable' clinical course. Patients in group 5 were not considered.
The effects of biometric features; features of the medical history; clinical, laboratory chemistry, microbiological, and radiological findings at admission; and various treatment regimens on a 'favourable' or 'unfavourable' clinical course were tested for significance (P<0.05) by means of the Kaplan-Meier survival analysis and the log rank test.
At the time point 14 days after the start of antibiotic therapy, the dependence of pain reduction and CRP reduction on initial intravenous therapy with a very effective antibiotic for 14 days was investigated in Fisher's exact test (desired significance level P<0.05; odds ratio with 95 % confidence interval).
RESULTS
During the selected time period, 57 patients met the clinical and radiological criteria for spondylodiscitis.
Medical history/clinical symptoms/inflammatory parameters at admission (Table 1 ) Primarily men at an advanced age with several previous diseases were affected. A likely focus of infection was identified in 67 % retrospectively. The majority had been treated in the hospital for another reason in the last 3 to 6 months prior to the current admission. The cardinal symptom was massive pain, which had already been present for a median of 4 weeks (1 day to 6 months), accompanied by a moderate CRP elevation and mild leukocytosis. Elevated temperatures or neurological deficits were present in one-third of patients.
In 10 patients the spondylodiscitis was a postoperative complication after spinal surgery (history of spinal surgeries in the past): six of these 10 patients had had an intervention because of a herniated intervertebral disc without implantation of any foreign material, in three patients a dorsal spondylodesis with dorsal stabilisation had been performed because of chronic degenerative diseases/spondylolisthesis (implantation of titanium material) and one patient had undergone a vertebral body replacement. The infection was detected between 3 weeks and 26 months post-intervention (median 3 months).
Radiological findings at admission (Table 1 ) Fulfillment of the spondylodiscitis criteria was retrospectively reviewed by a neuroradiologist. An MRI had been performed in the majority of patients; seven of these 41 patients (17 %) initially had only degenerative changes without specific evidence of spondylodiscitis. Especially in patients with a shorter duration of pain (2 days to 4 weeks), the diagnosis was made only at the repeat examination after 5-30 days.
Microbiological findings at admission
The pathogen was detected in 47 of 57 patients (82 %) (Fig. 1) . Forty percent of the infections were caused by Staphylococcus aureus, followed by about 20 % Streptococci/ Enterococci. Gramnegative roots (Escherichia coli) and Coagulase-negative staphylococci (CoNS) were detected in about 10 % of the patients. CoNS strains counted as relevant infectious agenspiration or simultaneously detected in the blood culture. Fungi and mycobacteria were not found. It was not screened for Brucellosis since it was not an endemic area.ts only if they were either confirmed during a second a Four out of 10 postoperative infections were caused by CoNS, three by S. aureus, one by Viridans streptococci and in two cases no pathogen was detected.
Initial blood cultures (<48 h) were taken from 46 of 57 patients, whereof in 28 patients a relevant pathogen was cultured (17 patients with S. aureus, seven with streptococci/ enterococci, three with E. coli, one with a relevant CoNSstrain (parallel detected in the CT-guided puncture), Fig. 1 red colums on the left. The positivity rate of the blood cultures was 61 %.
In 41 patients, a CT-guided aspiration of the intervertebral disc was performed promptly (<72 h), whereof in 29 patients a relevant pathogen was cultured (12 patients with S. aureus, eight with streptococci/enterococci, three with E. coli (not detected in the blood culture!) and six with relevant CoNSstrains): The positivity rate was 72 %.
The overall detection rate increased from 49 to 82 % (from 28 to 47 out of 57 patients) as a result of the combination of blood culture and CT-guided aspiration. No aspiration-related complications occurred. The specimens were announced to the laboratory by the radiologist and sent by a pneumatic delivery system in order to allow a fast processing (<15 min). Culture processing according to German microbiological infectious quality standards [12] (aerobic and anaerobic cultivation over 10 days) and a mycobacterial PCR (which was negative in all cases) were carried out. Additionally in one patient S. aureus was detected in a specimen acquired in an open surgery.
Since S. aureus was mainly detected by blood cultures (17 of 23 patients; exclusively by CT-guided puncture in four additional cases, Fig. 1 ). E. coli was detected in half of the cases by CT-guided puncture only (3 of 6). Relevant CoNS-infections were mainly detected by CT-guided puncture (6 of 7 cases).
Therapy
The majority (26 patients=46 %) underwent purely conservative therapy. Nine patients (16 %) underwent primary surgical treatment; four underwent subsequent surgical stabilisation; CT-guided drainage of abscesses caused by spondylodiscitis was performed in 12 patients.
Antibiotic therapy -efficacy (Table 2) and treatment duration The patients were initially treated intravenously for a median of 19 days (0-63 days) with an effective medication at a sufficient dosage (adjusted to renal and hepatic function). Twenty seven of the 47 patients with detection of a pathogen (57 %) initially received very effective, targeted i.v. therapy for at least 14 days.
For oral follow-up therapy, 32 patients received a very effective antibiotic, 15 received a weakly effective antibiotic, and two received an ineffective antibiotic. In the latter patients, clindamycin therapy was not adjusted based on the detected pathogen, E. coli and Enterococcus faecium, respectively, and led to an unfavourable clinical course (natural resistance).
The median overall treatment duration was 12 weeks (1-27 weeks; Table 3 ). The two patients with a recurrence had been treated for <6 weeks.
Thirty patients were assigned to the group 'timely' clinical course and 20 to the group 'prolonged' clinical course. Two patients were rehospitalised because of a recurrence; three died of spondylodiscitis-related sepsis, and two died of non-infectious causes (non-septical cerebral hemorrhage, decompensation of liver cirrhosis).
How did patients with a 'favourable' and 'unfavourable' clinical course differ (Table 3 , Fig. 2)? (a) at admission? Patient characteristics/findings at admission had no effect on the likelihood of a 'favourable' or 'unfavourable' clinical course, nor did age, sex, previous diseases, or previous hospitalisations or clinical symptoms (pain, fever, neurological deficits) or infectious parameters (leukocytosis, CRP, procalcitonin). Only the duration of pain differed in the two groups: the longer the pain had existed, the higher the risk for an unfavourable clinical course. When paraspinal (muscular) abscesses were detected, the clinical course tended to be more unfavourable; this result was just short of significance. The 10 patients with a postoperative spondylodiscitis had better chances to have a good clinical course than those with another focus of infection: nine of them had a favourable outcome, one had a prolonged disease course, there was no recurrence or death in this small subgroup.
(b) after 14 days of antibiotic therapy? In patients with a marked reduction in pain or reduction in the CRP after 14 days by at least 50 %, a 'favourable' clinical course was more likely (95 % versus 34 %; P<0.001 as well as 81 % versus 31 %; P=0.004 after 24 months). Pain reduction after 14 days was not an independent parameter because it represented one of three criteria for the group classification of 'favourable' versus 'unfavourable' clinical course. However, the significant difference was based on the classification to the groups according to the overall evaluation. For the classification of the groups, a CRP of <28 mg l À1 after 28 days (IDSA guideline) [6] was used. It was shown that both clinical course groups differ already after 14 days based on halving of the CRP. At the isolated time point 14 days after the start of antibiotic therapy, the CRP values in the patient group with the 'favourable' clinical course were significantly lower, whereas they had not differed at the start of treatment.
(c) regarding therapy? Whereas the need for surgical intervention or CT-guided abscess drainage had no impact, the selection of a very effective antibiotic had a decisive effect on the clinical course.
Initial intravenous administration of a very effective antibiotic for at least 14 days led to a favourable overall clinical course significantly more often. The longer intravenous therapy was administered, the more likely there was to be a 'favourable' clinical course without delayed healing, a recurrence, or infection-related death over an observation period of 48 months (P=0.006).
Follow-up therapy with a very effective antibiotic was also correlated with a more favourable overall clinical course.
A treatment duration of less than 6 weeks led to 'unfavourable' clinical courses more frequently than did at least 12 weeks of therapy (significant despite a low number of cases). The likelihood of a good healing process did not differ between a minimum treatment duration of 6 and 12 weeks.
All 10 patients with postoperative infections received an effective antibiotic therapy (including rifampicin in case of foreign material), in five out of six patients the infected foreign material was removed/replaced. Nine out of 10 patients had a 'favourable' outcome; only the one with the retained material (vertebral body replacement) had a 'prolonged' disease course.
DISCUSSION
The investigated patient collective was comparable to those in the literature in terms of demographic data, medical history and findings [4, 9, [13] [14] [15] [16] [17] [18] [19] [20] [21] . It consisted primarily of men (ratio 2.6 : 1) at an advanced age (median 70 years) with several previous diseases. Two-thirds had undergone inpatient treatment within the six months before the diagnosis was made. This supports the thesis that the increase in cases of spondylodiscitis reported in recent years is based on, among other things, a population that is becoming older, that more frequently undergoes invasive measures and immunosuppressive therapies [1, 3, 22] .
The cardinal symptom at admission was severe, almost uncontrollable (back) pain, usually combined with a moderate CRP elevation and mild leukocytosis -an overall relatively nonspecific constellation of findings. Thirty to seventy percent of the population experiences acute back pain at least once a year, which is usually functionally related or caused by degeneration and does not require extensive diagnostics and treatment [23] [24] [25] . It is therefore a challenge to recognise this 0.01 % with spondylodiscitis. The mean duration of pain of 4 weeks (up to 6 months in individual cases) at the time of the initial diagnosis illustrates the difficulty of establishing a diagnosis in the delicate balance between overdiagnosis and delayed treatment initiation [3, 17, 20, 22, 26, 27] . The absence of fever, possibly because of the use of antipyretic analgesics, is not an exclusion criterion [3, 6, 18, 22, 28] . Spondylodiscitis should also be considered if back pain occurs after a hospitalisation of several weeks. As we already know, [21] [22] [23] 27 , 29] a longer pain duration had an unfavourable effect on the healing process in this study as well.
Although MRI is the 'gold standard' for the diagnosis of spondylodiscitis (sensitivity: 93-96 %) [6, 10, 28, [30] [31] [32] [33] , it was initially still negative or showed nonspecific findings in 17 % of our patients, especially those with a short duration of pain. This supports the recommendation to repeat the examination after approximately 1-2 weeks if the findings are negative and clinical symptoms persist [5, 34] .
Bone infections require several weeks of antibiotic therapy. In any event, an attempt should be made to detect the pathogen because targeted antibiotic therapy is more effective [34] [35] [36] [37] and associated with fewer complications (e.g., less C. difficile-associated diarrhea) than is calculated therapy when the pathogen is unknown. The rise in multiresistant 'problem bacteria' that are not included in the standard broad-spectrum antibiotic regimen substantially increases the risk of treatment failures [37] .
With their low cost and good sensitivity (40-70 %) [6, 13, 16, 21, 22, 27, 28, 33, 34, 38] , blood cultures should be part of the basic diagnostics when spondylodiscitis is suspected, regardless of the presence of fever. In the investigated study collective, this simple measure also increased the pathogen detection rate.
In stable patients (with the exception of septic or immunosuppressed patients or patients with neurological deficits), direct material sampling at the site of the infection should take place prior to the start of antibiotic therapy [5, 6, 17, 26, 33, 35, 39, 40] . If there is no indication for surgery (compression syndrome, instability), CT-guided aspiration of the intervertebral disc by an experienced examiner is an effective and low-risk method (sensitivity 36-91 %) [2, 13, 18, 27, 38, 41] . Combination with CT-guided aspiration allowed additional pathogen detection in one-third of the patients in this study collective. If a relevant infectious agent (e.g. S. aureus) is detected in the blood culture, CT-guided aspiration can be omitted [6] . *if 'S' tested; **For staphylococcal infections with foreign material, only combination therapy with a 'biofilm-active' antibiotic was considered to be 'very effective'; ***after inducible clindamycin resistance was ruled out. The table presents the evaluation of the antibiotics used in this study cohort and is not a generally valid primary treatment recommendation! A requirement for such high detection rates is optimal microbiological diagnostics, including a good infrastructure (storage and transport times for the aspirate max. 10-15 min.). Whether additionally performing a eubacterial or fungal PCR for culture-negative samples (especially in patients previously treated with antibiotics) can achieve an increase in the detection rate [6, 42, 43] requires further investigation in larger patient collectives. A simultaneous histological examination is reasonable, so that when bacterial detection is negative, the inflammatory reaction is confirmed and other differential diagnoses, e.g., tumors, are not overlooked [6, 34, 35, 40] .
In stable patients, one can wait for the culture results. If no bacteria are detected, CT-guided aspiration can be repeated (again a similar detection rate) [44] or other invasive techniques for acquiring material (percutaneous endoscopic or open surgical measures) can be performed [6, 27, 28, 35, 40, 41, 45] . There are no clear guidelines in this regard. Fig. 3 presents a flow chart for a possible course of diagnostics and treatment.
If pathogen detection is unsuccessful or one cannot wait for the results, calculated antibiotic therapy should cover the most common pathogens (30-80 % S. aureus, approximately 20 % streptococci/enterococci, each 10-20 % CoNS and gram-negative bacteria [4, 6, 14-18, 22, 26, 38] (Fig. 1): e.g., flucloxacillin +third generation cephalosporin ±rifam-mpicin (foreign material) [17, 28] . There is a higher proportion of CoNS in postoperative infections (in our small cohort 4/10 versus 3/47 patients). Therefore for postoperative spondylodiscitis or when the MRSA risk is increased, flucloxacillin should be replaced by, e.g. vancomycin. Multiresistant or rare pathogens such as fungi, mycobacteria, or Brucella are not usually covered by calculated initial therapy [37] . When pathogen detection is successful, the antibiotic therapy should be adjusted.
What effect does the treatment regimen have on the healing process?
To investigate the effect of the therapeutic design, patients with a 'favourable' healing process were compared with those with an 'unfavourable' healing process. For the 'unfavourable' clinical course group, hard criteria such as 'recurrence' and 'spondylodiscitis-related death' were summarised with the 'prolonged' clinical course. Because there is no clear definition for a 'timely' vs. 'prolonged' healing process thus far, the following main criteria for treatment success used in everyday practice were considered: decrease in pain, changes in CRP, improvement/stability of the radiological findings. This 'soft' demarcation represents a limitation of this study.
The majority of the study patients were -as described in the literature [16, 22, 28 ] -treated conservatively. The indication for surgical revision or CT-guided abscess drainage (compression syndrome, imminent instability) was established individually by neurosurgeons and neuroradiologists; however, the need for them had no effect on the likelihood of a 'favourable' clinical course.
This study was able to corroborate for the first time that optimal antibiotic therapy is a decisive factor in determining the healing process. Since there were no guidelines for the therapy of spondylodiscitis available in the English or German speaking area at that time (2012/2013) very different antibiotic regimen were applied. Initial intravenous therapy with a very effective medication (especially a bactericidal beta-lactam) for at least 14 days was significantly associated with overall favourable treatment results ('favourable outcome' after 24 months: 96 % vs 30 %; P<0.001; Table 3 , Fig. 2 ). The longer the patient received targeted intravenous therapy, the more likely treatment success was.
Evaluation of the efficacy of the antibiotics in terms of the detected pathogens (Table 2 ) was carried out according to microbiological and pharmacological data (bactericidal effect, resistance, bioavailability, tissue penetration) on the basis of the few available pathogen-related treatment recommendations [5-7, 28, 33, 34] . For the dominant staphylococcal infections, high-dose initial intravenous therapy with a suitable beta-lactam (flucloxacillin, alternatively first-or second-generation cephalosporin) had a decisive effect on the better treatment process. Initial therapy with bacteriostatic clindamycin often led to delayed healing or even death in case of sepsis. However, individual antibiotic combinations could not be compared because of the low number of patients.
This highlights the need to establish antimicrobial stewardship programs and microbiological/infectious disease advising/consulting regarding targeted antibiotic therapy. The selection of the 'correct' antibiotic therapy for spondylodiscitis is complicated by the lack of appropriate guidelines. Prospective studies comparing various antibiotic regimens based on the pathogen would be desirable [18, 29, 46] .
The total treatment duration should be no less than 6 weeks to avoid recurrences and other complications [6, 13, 18, 26, 28, 29] . The two patients in this study with recurrences were also treated for less than 6 weeks. Many centers prefer a minimum treatment duration of 12 weeks [6, 22, 33] . Bernard et al. [47] and Roblot et al. [16] showed for the first time that a minimum treatment duration of 6 weeks is not necessarily inferior to a minimum treatment duration of 12 weeks. But the study design of this paper was not appropriate to make a statement for the duration of antibiotic therapies because of multiple other influences.
The therapeutic concept (indication for surgery/abscess drainage, optimal antibiotic therapy) for this protracted infection should be established by an interdisciplinary team experienced in the treatment of patients with spondylodiscitis (neurosurgeon/radiologist/microbiologist or infectious disease specialist/orthopedist/pain therapy specialist). 
Monitoring of treatment results
At the time point 14 days after the start of antibiotic therapy, both pain reduction and a CRP reduction of at least 50 % are good parameters of effective antibiotic therapy and a favourable overall clinical course [9, 15, 19, 22, 28, 48] . The radiological findings can 'lag behind' at this time point (increase in bone edema, not of the abscesses) without this being regarded as a treatment failure. Repeat radiological examinations for uncomplicated clinical courses are therefore frequently no longer recommended in recent publications [6, 8, 15, 28, 29, 49] .
On the other hand, treatment failure should be considered; i.e. the antibiotic therapy should be optimised (with repeat pathogen detection) and complications (e.g. abscess formation/empyema/endocarditis) should be ruled out [9, 14, 16, 22, 27, 28, 33, 50] .
Limitations
The size of the population was relatively small due to the low incidence of the disease, rising just recently during the last years. We probably saw the more serious cases because the hospital is a tertiary care referral hospital -possibly explaining the high proportion of abscesses. One must assume that the less serious (self-limiting) cases were not found in former years because of the lack of awareness of the disease. The retrospective study design and the low number of patients did not allow to compare different antibiotic strategies for the same pathogen (pathogen directed therapy) -for spondylodiscitis this is not available in the literature so far. Additionally there might be missed endocarditis cases due to the low rate of transoesophageal echocardiography (25/57 patients), even though the three cases of endocarditis were treated for more than 6 weeks intravenously.
With all the limitations this study shows that prompt diagnosis and optimised antibiotic therapy have a decisive effect on the healing process of spondylodiscitis.
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